MedPath

Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer

Phase 3
Completed
Conditions
Fatigue
Unspecified Adult Solid Tumor, Protocol Specific
Registration Number
NCT00042848
Lead Sponsor
Gary Morrow
Brief Summary

RATIONALE: Modafinil may be effective in relieving fatigue in patients with cancer who are undergoing chemotherapy. The effectiveness of modafinil in relieving chemotherapy-related fatigue is not yet known.

PURPOSE: This randomized phase III trial is studying the effectiveness of modafinil in treating fatigue in patients who are receiving chemotherapy for cancer.

Detailed Description

OBJECTIVES:

* Assess the degree to which modafinil can reduce fatigue in cancer patients receiving chemotherapy.

* Assess the relationship between depression and fatigue in patients treated with this drug.

OUTLINE: This is a randomized, double-blind, placebo-controlled, multicenter study. Patients are randomized to 1 of 2 treatment arms.

* Arm I: Beginning on day 5 of the second course of chemotherapy, patients receive oral modafinil once daily.

* Arm II: Beginning on day 5 of the second course of chemotherapy, patients receive oral placebo once daily.

Treatment in both arms continues until day 7 of course 4 of chemotherapy in the absence of disease progression or unacceptable toxicity.

Fatigue and quality of life are assessed on day 7 of courses 2-4 of chemotherapy.

PROJECTED ACCRUAL: A total of 837 patients will be accrued for this study within approximately 2.5 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
837
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy to reduce fatigue during chemotherapy as assessed by the Brief Fatigue Inventory at course 4
Secondary Outcome Measures
NameTimeMethod
Relationship between depression and fatigue during chemotherapy as assessed by Fatigue Symptom Checklist, Profile of Mood States, Fatigue Severity Scale, Epworth Sleepiness Scale, Center for Epidemiologic Studies-Depression, and Mini-Mac at course 4

Trial Locations

Locations (35)

MBCCOP - Gulf Coast

🇺🇸

Mobile, Alabama, United States

CCOP - Western Regional, Arizona

🇺🇸

Phoenix, Arizona, United States

CCOP - Santa Rosa Memorial Hospital

🇺🇸

Santa Rosa, California, United States

Medical Center of Aurora - South Campus

🇺🇸

Aurora, Colorado, United States

Boulder Community Hospital

🇺🇸

Boulder, Colorado, United States

Penrose Cancer Center at Penrose Hospital

🇺🇸

Colorado Springs, Colorado, United States

Porter Adventist Hospital

🇺🇸

Denver, Colorado, United States

St. Joseph Hospital

🇺🇸

Denver, Colorado, United States

Presbyterian - St. Luke's Medical Center

🇺🇸

Denver, Colorado, United States

Rocky Mountain Cancer Centers - Denver Rose

🇺🇸

Denver, Colorado, United States

Scroll for more (25 remaining)
MBCCOP - Gulf Coast
🇺🇸Mobile, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.